The impact of weight gain on quality of life among persons with schizophrenia

Psychiatric Services

Volumn 54, Issue 4, 2003, Pages 565-567

  Allison, David B ^a   Mackell, Joan A ^b   McDonnell, Diana D ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b PFIZER INC   (United States)

^c Consumer Health Sciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; QUALITY OF LIFE; SCHIZOPHRENIA; SELF REPORT; SEX DIFFERENCE; WEIGHT GAIN; WELLBEING;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF ASSESSMENT (PSYCHOLOGY); SICKNESS IMPACT PROFILE; UNITED STATES; WEIGHT GAIN;

EID: 0038714243     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.54.4.565     Document Type: Article

References (10)

1. Allison DB, Mentore JL, Heo M, et al: Antipsychotic-induced weiglit gain: 4 comprehensive research synthesis. American Journal of Psychiatry 156:1686-1696, 1999
2. Allison DB, Fontaine KR, Heo M, et al: The distribution of body mass index among individuals with and without schizophrenia. Journal of Clinical Psychiatry 60:215-220, 1999
3. Fontaine KR, Bartlett SJ, Barofsky I: Health-related quality of life among obese persons seeldng and not currently seeking treatment. International Journal of Eating Disorders 27:101-105, 2000
4. Weiden PJ, Mackell J, McDonnelI DD: Obesity as a risk factor for antipsychotic noncompliance. Presented at the Annual New Clinical Drug Evaluation Unit (NCDEU) Conference, Boca Raton, Fla, May 30 to June 2, 2000
5. Perkins DO: Adherence to antipsychotic medications. Journal of Clinical Psychiatry 60(suppl 21):25-30, 1999
6. Naber D, Holzbach R, Perro C, et al: Clinical management of clozapine patients in relation to efficcacy and side-effects. British Journal of Psychiatry 160(suppl 17):54-59, 1992
7. Fakhouri W: Extent of distress caused by adverse experiences associated with antipsychotic treatment. Presented at the European College of Neuropsychopharmacology Congress, London; United Kingdom, Sept 21-25, 1999
8. Dupuy H: The Psychological General Well-Being (PGWB) Index, in Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Edited by Wenger N, Mattson M, Furberg C, et al. Greenwich, Conn, Le Jacq, 1984
9. Heymsfield S, Allison D, Heshka S, et al: Assessment of human body composition, in Handbook of Assessment Methods for Eating Behaviors and Weight Related Problems: Measures, Theory, and Research. Edited by Allison DB. Thousand Oaks, Calif, Sage, 1995
10. Weiden PJ, Mackell J, McDonnell DD: Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research, in press